{"analyses":[{"groupDescription":"3 months","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.74","statisticalComment":"2-sided significance level of 0.05","statisticalMethod":"Kolmogorov-Smirnov"},{"groupDescription":"12 months","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.99","statisticalComment":"2-sided significance level of 0.05","statisticalMethod":"Kolmogorov-Smirnov"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.18","value":"0.78"},{"groupId":"OG001","spread":"0.15","value":"0.77"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"316"},{"groupId":"OG001","value":"289"}],"units":"Participants"}],"title":"EQ-5D 3 months"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.17","value":"0.84"},{"groupId":"OG001","spread":"0.16","value":"0.84"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"243"},{"groupId":"OG001","value":"253"}],"units":"Participants"}],"title":"EQ-5D 12 months"}],"denoms":[{"counts":[{"groupId":"OG000","value":"447"},{"groupId":"OG001","value":"444"}],"units":"Participants"}],"description":"The EQ-5D is a 2-part self-assessment questionnaire. First part is 5 items (mobility, self care, usual activities, pain/discomfort, anxiety/depression) each with 3 problem levels (1-none, 2-moderate, 3-extreme). Health states are defined by the combination of the leveled responses to the 5 dimensions, generating 243 health states to which unconsciousness and death are added. The 2nd part is a visual analogue scale (VAS) valuing current health state, measured on a 20-cm 10-point interval scale. Worst imaginable health state is scored as 0 at the bottom of the scale, and best imaginable health state is scored as 100 at the top. Both the 5-item index score and the VAS score are transformed into a utility score between 0 (worst health state) and 1 (best health state).","dispersionType":"Standard Deviation","groups":[{"description":"Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin","id":"OG000","title":"RT + Cisplatin"},{"description":"Radiation therapy (RT) as accelerated fractionation by concomitant boost (AFX-CB) or intensity-modulated radiation therapy (IMRT) plus cisplatin plus cetuximab","id":"OG001","title":"RT + Cisplatin + Cetuximab"}],"paramType":"MEAN","populationDescription":"Randomized eligible patients with EQ-5D data at the given time point.","reportingStatus":"POSTED","timeFrame":"3 months and 12 months","title":"Quality of Life as Measured by European Quality of Life Questionnaire (EQ-5D)","type":"SECONDARY","unitOfMeasure":"units on a scale"}